[HTML][HTML] Activating JAK1 mutation may predict the sensitivity of JAK-STAT inhibition in hepatocellular carcinoma
S Yang, C Luo, Q Gu, Q Xu, G Wang, H Sun, Z Qian… - Oncotarget, 2016 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is the fifth most common type of cancers worldwide.
However, current therapeutic approaches for this epidemic disease are limited, and its 5 …
However, current therapeutic approaches for this epidemic disease are limited, and its 5 …
[引用][C] Activating JAK1 mutation may predict the sensitivity of JAK-STAT inhibition in hepatocellular carcinoma
S Yang, C Luo, Q Gu, Q Xu, G Wang, H Sun, Z Qian… - Oncotarget, 2015 - cir.nii.ac.jp
Activating <i>JAK1</i> mutation may predict the sensitivity of JAK-STAT inhibition in
hepatocellular carcinoma | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …
hepatocellular carcinoma | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …
Activating JAK1 mutation may predict the sensitivity of JAK-STAT inhibition in hepatocellular carcinoma
S Yang, C Luo, Q Gu, Q Xu, G Wang, H Sun… - …, 2016 - pubmed.ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is the fifth most common type of cancers worldwide.
However, current therapeutic approaches for this epidemic disease are limited, and its 5 …
However, current therapeutic approaches for this epidemic disease are limited, and its 5 …
[HTML][HTML] Activating JAK1 mutation may predict the sensitivity of JAK-STAT inhibition in hepatocellular carcinoma
S Yang, C Luo, Q Gu, Q Xu, G Wang, H Sun, Z Qian… - Oncotarget, 2015 - oncotarget.com
Abstract Shuqun Yang 1, Chonglin Luo 1, Qingyang Gu 1, Qiang Xu 2, Guan Wang 2,
Hongye Sun 2, Ziliang Qian 3, Yexiong Tan 4, Yuxin Qin 1, Yuhong Shen 1, Xiaowei Xu 5 …
Hongye Sun 2, Ziliang Qian 3, Yexiong Tan 4, Yuxin Qin 1, Yuhong Shen 1, Xiaowei Xu 5 …
[PDF][PDF] Activating JAK1 mutation may predict the sensitivity of JAK-STAT inhibition in hepatocellular carcinoma
S Yang, C Luo, Q Gu, Q Xu, G Wang, H Sun, Z Qian… - pdfs.semanticscholar.org
Hepatocellular carcinoma (HCC) is the fifth most common type of cancers worldwide.
However, current therapeutic approaches for this epidemic disease are limited, and its 5 …
However, current therapeutic approaches for this epidemic disease are limited, and its 5 …
Activating JAK1 mutation may predict the sensitivity of JAK-STAT inhibition in hepatocellular carcinoma.
S Yang, C Luo, Q Gu, Q Xu, G Wang, H Sun, Z Qian… - Oncotarget, 2016 - europepmc.org
Hepatocellular carcinoma (HCC) is the fifth most common type of cancers worldwide.
However, current therapeutic approaches for this epidemic disease are limited, and its 5 …
However, current therapeutic approaches for this epidemic disease are limited, and its 5 …
Activating JAK1 mutation may predict the sensitivity of JAK-STAT inhibition in hepatocellular carcinoma.
S Yang, C Luo, Q Gu, Q Xu, G Wang, H Sun, Z Qian… - Oncotarget, 2016 - europepmc.org
Hepatocellular carcinoma (HCC) is the fifth most common type of cancers worldwide.
However, current therapeutic approaches for this epidemic disease are limited, and its 5 …
However, current therapeutic approaches for this epidemic disease are limited, and its 5 …
Activating JAK1 mutation may predict the sensitivity of JAK-STAT inhibition in hepatocellular carcinoma
S Yang, C Luo, Q Gu, Q Xu, G Wang, H Sun, Z Qian… - Oncotarget, 2015 - oncotarget.com
Abstract Shuqun Yang 1, Chonglin Luo 1, Qingyang Gu 1, Qiang Xu 2, Guan Wang 2,
Hongye Sun 2, Ziliang Qian 3, Yexiong Tan 4, Yuxin Qin 1, Yuhong Shen 1, Xiaowei Xu 5 …
Hongye Sun 2, Ziliang Qian 3, Yexiong Tan 4, Yuxin Qin 1, Yuhong Shen 1, Xiaowei Xu 5 …